The HepAK 7plus Dot is a qualitative dot immunoassay for the determination of IgG antibodies against M2, gp210, sp100, LKM1, LC1, SLA and F-actin in human serum. The HepAK 7plus Dot is intended as an aid in the diagnosis of autoimmune liver diseases in conjunction with other clinical and laboratory findings. The immunoassay is designed for manual professional in vitro diagnostic use.
4099 – HepAK 7plus Dot
Autoimmunity, Diagnostics, LINE / Dot
4099 – HepAK 7plus Dot
Dot Immunoassay for the qualitative determination of IgG antibodies against M2, gp210, sp100, LKM1, LC1, SLA and F-actin in human serum
Available Downloads:
| Indication | Autoimmune liver disease |
|---|---|
| Format | Test strips coated with M2, gp210, sp100, LKM1, LC1, SLA and F-actin |
| Total incubation time | 80 min |
| Sample volume | 10 µL serum |
| No. of determinations | 24 x 7 |
Related products
-
3810 – GliaDea IgG
Enzyme immunoassay for the quantitative determination of IgG antibodies against deamidated gliadin in human serum
-
3900 – Anti-ASGPR
Enzyme immunoassay for the semi-quantitative determination of IgG antibodies against asialoglycoprotein receptor in human serum
-
3002 – Medizym® anti-TPO
Enzyme immunoassay for the quantitative determination of IgG antibodies against thyroid peroxidase (TPO) in human serum